APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Osteoarthritis Pain

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Selected research

Industry Growth & Trends

Global Drugs for Osteoarthritis Pain Industry Growth and Trends Forecast to 2032

22 December 2025111 pages

Choose your research edition.

Industry ResearchDrugs for Osteoarthritis Pain Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Osteoarthritis Pain Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Drugs for Osteoarthritis Pain Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Osteoarthritis Pain Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Osteoarthritis Pain Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

According to APO Research, the global Drugs for Osteoarthritis Pain market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Drugs for Osteoarthritis Pain market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Osteoarthritis Pain market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Osteoarthritis Pain market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Osteoarthritis Pain.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drugs for Osteoarthritis Pain market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Osteoarthritis Pain Market by Company

Pfizer

Johnson & Johnson

GlaxoSmithKline

Bayer

Eli Lilly

Novartis

Sanofi

Horizon Pharma

Abbott

Mylan

Daiichi Sankyo

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Drugs for Osteoarthritis Pain Segment by Type

Oral

Injection

External

Drugs for Osteoarthritis Pain Segment by Application

Medical Care

Personal Care

Drugs for Osteoarthritis Pain Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Osteoarthritis Pain market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Osteoarthritis Pain and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Osteoarthritis Pain.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drugs for Osteoarthritis Pain companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Osteoarthritis Pain Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drugs for Osteoarthritis Pain Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drugs for Osteoarthritis Pain Market Share by Region (2021-2026) Table 4. Global Drugs for Osteoarthritis Pain Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drugs for Osteoarthritis Pain Market Share by Region (2027-2032) Table 6. Global Drugs for Osteoarthritis Pain Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drugs for Osteoarthritis Pain Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2026) Table 9. Global Drugs for Osteoarthritis Pain Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drugs for Osteoarthritis Pain Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drugs for Osteoarthritis Pain Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drugs for Osteoarthritis Pain Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2026) Table 24. Global Drugs for Osteoarthritis Pain Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drugs for Osteoarthritis Pain Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drugs for Osteoarthritis Pain Industry Trends Table 37. Drugs for Osteoarthritis Pain Industry Drivers Table 38. Drugs for Osteoarthritis Pain Industry Opportunities and Challenges Table 39. Drugs for Osteoarthritis Pain Industry Restraints Table 40. Global Drugs for Osteoarthritis Pain Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drugs for Osteoarthritis Pain Revenue Market Share by Company (2021-2026) Table 42. Global Drugs for Osteoarthritis Pain Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drugs for Osteoarthritis Pain Key Company Headquarters & Area Served Table 44. Global Drugs for Osteoarthritis Pain Company, Product Type & Application Table 45. Global Drugs for Osteoarthritis Pain Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Pfizer Drugs for Osteoarthritis Pain Product Portfolio Table 52. Pfizer Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. GlaxoSmithKline Company Information Table 59. GlaxoSmithKline Business Overview Table 60. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio Table 62. GlaxoSmithKline Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bayer Drugs for Osteoarthritis Pain Product Portfolio Table 67. Bayer Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Drugs for Osteoarthritis Pain Product Portfolio Table 77. Novartis Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sanofi Drugs for Osteoarthritis Pain Product Portfolio Table 82. Sanofi Recent Development Table 83. Horizon Pharma Company Information Table 84. Horizon Pharma Business Overview Table 85. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 87. Horizon Pharma Recent Development Table 88. Abbott Company Information Table 89. Abbott Business Overview Table 90. Abbott Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Abbott Drugs for Osteoarthritis Pain Product Portfolio Table 92. Abbott Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Mylan Drugs for Osteoarthritis Pain Product Portfolio Table 97. Mylan Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. TEVA Company Information Table 104. TEVA Business Overview Table 105. TEVA Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. TEVA Drugs for Osteoarthritis Pain Product Portfolio Table 107. TEVA Recent Development Table 108. Almatica Pharma Company Information Table 109. Almatica Pharma Business Overview Table 110. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 112. Almatica Pharma Recent Development Table 113. Astellas Pharma Company Information Table 114. Astellas Pharma Business Overview Table 115. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 117. Astellas Pharma Recent Development Table 118. Tide Pharmaceutical Company Information Table 119. Tide Pharmaceutical Business Overview Table 120. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio Table 122. Tide Pharmaceutical Recent Development Table 123. Iroko Pharmaceuticals Company Information Table 124. Iroko Pharmaceuticals Business Overview Table 125. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio Table 127. Iroko Pharmaceuticals Recent Development Table 128. Hengrui Pharmaceutical Company Information Table 129. Hengrui Pharmaceutical Business Overview Table 130. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio Table 132. Hengrui Pharmaceutical Recent Development Table 133. Abiogen Pharma Company Information Table 134. Abiogen Pharma Business Overview Table 135. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio Table 137. Abiogen Pharma Recent Development Table 138. North America Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Drugs for Osteoarthritis Pain Market Share by Country (2021-2026) Table 141. North America Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Drugs for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 143. Europe Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Drugs for Osteoarthritis Pain Market Share by Country (2021-2026) Table 146. Europe Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Drugs for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Country (2021-2026) Table 151. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Drugs for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 153. Latin America Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2021-2026) Table 156. Latin America Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Drugs for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2021-2026) Table 161. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Drugs for Osteoarthritis Pain Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drugs for Osteoarthritis Pain Product Image Figure 3. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drugs for Osteoarthritis Pain Market Size (2021-2032) & (US$ Million) Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Region: 2025 VS 2032 Figure 6. Global Drugs for Osteoarthritis Pain Market Share by Region (2021-2032) Figure 7. North America Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Oral Image Figure 13. Global Oral Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Injection Image Figure 15. Global Injection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. External Image Figure 17. Global External Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Drugs for Osteoarthritis Pain Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Drugs for Osteoarthritis Pain Market Share by Type 2025 VS 2032 Figure 20. North America Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032) Figure 21. Europe Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032) Figure 23. Latin America Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Share by Type (2021-2032) Figure 25. Medical Care Image Figure 26. Global Medical Care Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Personal Care Image Figure 28. Global Personal Care Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Drugs for Osteoarthritis Pain Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Drugs for Osteoarthritis Pain Market Share by Application 2025 VS 2032 Figure 31. North America Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032) Figure 32. Europe Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032) Figure 34. Latin America Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Drugs for Osteoarthritis Pain Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Drugs for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Drugs for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 41. Europe Drugs for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Drugs for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 44. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 47. Latin America Drugs for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Drugs for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 50. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
  • External
Applications
  • Medical Care
  • Personal Care
Companies covered
  • Pfizer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer
  • Eli Lilly
  • Novartis
  • Sanofi
  • Horizon Pharma
  • Abbott
  • Mylan
  • Daiichi Sankyo
  • TEVA
  • Almatica Pharma
  • Astellas Pharma
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Hengrui Pharmaceutical
  • Abiogen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drugs for Osteoarthritis Pain Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drugs for Osteoarthritis Pain Market Size by Region (2021-2032)
  5. 1.4.1 Global Drugs for Osteoarthritis Pain Market Size by Region (2021-2026)
  6. 1.4.2 Global Drugs for Osteoarthritis Pain Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drugs for Osteoarthritis Pain Market Size (2021-2032)
  8. 1.5.1 North America Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate (2021-2032)
2 Drugs for Osteoarthritis Pain Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Oral
  3. 2.1.2 Injection
  4. 2.1.3 External
  5. 2.2 Global Drugs for Osteoarthritis Pain Market Size by Type
  6. 2.2.1 Global Drugs for Osteoarthritis Pain Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Drugs for Osteoarthritis Pain Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Drugs for Osteoarthritis Pain Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Drugs for Osteoarthritis Pain Market Size by Regions
  10. 2.3.1 North America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Type (2021-2026)
3 Drugs for Osteoarthritis Pain Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Care
  3. 3.1.2 Personal Care
  4. 3.2 Global Drugs for Osteoarthritis Pain Market Size by Application
  5. 3.2.1 Global Drugs for Osteoarthritis Pain Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Drugs for Osteoarthritis Pain Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Drugs for Osteoarthritis Pain Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Drugs for Osteoarthritis Pain Market Size by Regions
  9. 3.3.1 North America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Drugs for Osteoarthritis Pain Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drugs for Osteoarthritis Pain Industry Trends
  2. 4.2 Drugs for Osteoarthritis Pain Industry Drivers
  3. 4.3 Drugs for Osteoarthritis Pain Industry Opportunities and Challenges
  4. 4.4 Drugs for Osteoarthritis Pain Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drugs for Osteoarthritis Pain Revenue (2021-2026)
  2. 5.2 Global Drugs for Osteoarthritis Pain Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drugs for Osteoarthritis Pain Key Company Headquarters & Area Served
  4. 5.4 Global Drugs for Osteoarthritis Pain Company, Product Type & Application
  5. 5.5 Global Drugs for Osteoarthritis Pain Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drugs for Osteoarthritis Pain Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drugs for Osteoarthritis Pain Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drugs for Osteoarthritis Pain Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Drugs for Osteoarthritis Pain Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 GlaxoSmithKline
  14. 6.3.1 GlaxoSmithKline Company Information
  15. 6.3.2 GlaxoSmithKline Business Overview
  16. 6.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Portfolio
  18. 6.3.5 GlaxoSmithKline Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Drugs for Osteoarthritis Pain Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Drugs for Osteoarthritis Pain Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Drugs for Osteoarthritis Pain Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Drugs for Osteoarthritis Pain Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
  43. 6.8 Horizon Pharma
  44. 6.8.1 Horizon Pharma Company Information
  45. 6.8.2 Horizon Pharma Business Overview
  46. 6.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Product Portfolio
  48. 6.8.5 Horizon Pharma Recent Developments
  49. 6.9 Abbott
  50. 6.9.1 Abbott Company Information
  51. 6.9.2 Abbott Business Overview
  52. 6.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Abbott Drugs for Osteoarthritis Pain Product Portfolio
  54. 6.9.5 Abbott Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Drugs for Osteoarthritis Pain Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 TEVA
  68. 6.12.1 TEVA Company Information
  69. 6.12.2 TEVA Business Overview
  70. 6.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 TEVA Drugs for Osteoarthritis Pain Product Portfolio
  72. 6.12.5 TEVA Recent Developments
  73. 6.13 Almatica Pharma
  74. 6.13.1 Almatica Pharma Company Information
  75. 6.13.2 Almatica Pharma Business Overview
  76. 6.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Product Portfolio
  78. 6.13.5 Almatica Pharma Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Tide Pharmaceutical
  86. 6.15.1 Tide Pharmaceutical Company Information
  87. 6.15.2 Tide Pharmaceutical Business Overview
  88. 6.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
  90. 6.15.5 Tide Pharmaceutical Recent Developments
  91. 6.16 Iroko Pharmaceuticals
  92. 6.16.1 Iroko Pharmaceuticals Company Information
  93. 6.16.2 Iroko Pharmaceuticals Business Overview
  94. 6.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Portfolio
  96. 6.16.5 Iroko Pharmaceuticals Recent Developments
  97. 6.17 Hengrui Pharmaceutical
  98. 6.17.1 Hengrui Pharmaceutical Company Information
  99. 6.17.2 Hengrui Pharmaceutical Business Overview
  100. 6.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Portfolio
  102. 6.17.5 Hengrui Pharmaceutical Recent Developments
  103. 6.18 Abiogen Pharma
  104. 6.18.1 Abiogen Pharma Company Information
  105. 6.18.2 Abiogen Pharma Business Overview
  106. 6.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Product Portfolio
  108. 6.18.5 Abiogen Pharma Recent Developments
7 North America
  1. 7.1 North America Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  3. 7.3 North America Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  3. 8.3 Europe Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  3. 10.3 South America Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst